Controlled delivery of low-dose bone morphogenetic protein-2 using heparin-conjugated fibrin in the posterolateral lumbar fusion of rabbits 2018-07-19 cgbio 조회수Views : 602 다음글Efficacy of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in posterolateral lumbar fusion: an open, active-controlled, randomized, multicenter trial 이전글Autologous mesenchymal stem cell (MSCs) transplantation forcritical-sized bone defect following a wide excision of osteofibrousdysplasia
